- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07701603
Effects of Blood Gas Perturbations
July 8, 2026 updated by: Swiss Federal Institute of Technology
Effects of Blood Gas Perturbations on Neuromuscular Function of the Diaphragm and Lower Limbs at Rest and During Exercise.
In this study, the effects of blood gas perturbations on neuromuscular function of the diaphragm and lower limbs at rest and during exercise will be investigated.
Study Overview
Study Type
Interventional
Enrollment (Estimated)
16
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Christina M. Spengler, Prof.
- Phone Number: +41 44 632 5007
- Email: christina.spengler@hest.ethz.ch
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- healthy
- non.smoking
- normal lung function
- BMI: 18.5-29.9 kg/m2
- willing to adhere to study rules
Exclusion Criteria:
- Acute illness or chronic conditions of the gastrointestinal tract, and health conditions affecting metabolism, the cardiovascular or the respiratory system, or sleep
- Intake of medications affecting metabolism, the cardiovascular, the neuromuscular or the respiratory system, or sleep
- Any metal or electronics inside of the body
- Presence of cardiac pacemaker, implanted defibrillators or implanted neurostimulators
- History of seizures or epilepsy
- Tattoos on the stimulation sites
- Previous enrolment in this study
- For women: Pregnancy, breastfeeding, or intention to become pregnant during the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Gas perturbations
Each participant will be tested on 4 different days, on each day with a different inspiratory gas mixture applied for 2h.
|
Participants will be breathing a gas mixture of either room air, or hypoxia, or hypercapnia, or a combination of both during 2h.
This is followed by an all-out breathing exercise test against a small resistance, while still being in the respective gas condition.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diaphragm contractility
Time Frame: Continuously measured from 10 sec before until 10 sec after each stimulation. One stimulation lasts for approx. 1 sec
|
Diaphragm contractility measured before/during/following the gas exposures and the volitional respiratory muscle exercises using transdiaphragmatic and mouth pressure responses.
|
Continuously measured from 10 sec before until 10 sec after each stimulation. One stimulation lasts for approx. 1 sec
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quadriceps contractility
Time Frame: Continuously measured from 10 sec before until 10 sec after each stimulation. One stimulation lasts for approx. 1 sec.
|
Quadriceps contractility will be assess before, during and following the gas exposures and respiratory muscle contractions
|
Continuously measured from 10 sec before until 10 sec after each stimulation. One stimulation lasts for approx. 1 sec.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Spengler M. Christina, Prof., Exercise Physiology Lab, Department of Health Sciences and Technology
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
August 31, 2026
Primary Completion (Estimated)
December 31, 2029
Study Completion (Estimated)
December 31, 2029
Study Registration Dates
First Submitted
July 8, 2026
First Submitted That Met QC Criteria
July 8, 2026
First Posted (Actual)
July 14, 2026
Study Record Updates
Last Update Posted (Actual)
July 14, 2026
Last Update Submitted That Met QC Criteria
July 8, 2026
Last Verified
July 1, 2026
More Information
Terms related to this study
Other Study ID Numbers
- REMEX-WP3
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.